{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T01:19:37Z","timestamp":1774055977748,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The purpose of the present study was to translate and cross-culturally adapt the King\u2019s Parkinson\u2019s Disease Pain Scale (KPPS) into Bulgarian and to investigate its psychometric properties in order to provide a validated Parkinson\u2019s disease-specific pain instrument in Bulgarian language (KPPS-BG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Translation into Bulgarian and a cultural adaptation were performed to obtain KPPS-BG. A total of 162 patients with idiopathic Parkinson\u2019s disease were screened for pain using the complementary to the KPPS questionnaire \u2013 King\u2019s Parkinson\u2019s Disease Pain Questionnaire (KPPQ). KPPS-BG domain and total scores were calculated and internal consistency, construct validity and test-retest reliability were examined for 129 patients having one or more positive items in the KPPQ-BG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>79.6\u2009% of the patients reported one or more types of pain. The most common type was musculoskeletal pain (83.7\u2009%), followed by nocturnal pain (55.0\u2009%), fluctuation-related pain (50.1\u2009%), radicular pain (43.4\u2009%), chronic pain (31.0\u2009%), discoloration, edema\/swelling (27.1\u2009%) and, oro-facial pain (14.3\u2009%). Mean KPPS-BG total score was 21.1\u2009\u00b1\u200917.3 SD. KPPS-BG showed a good reliability (Cronbach\u2019s alpha 0.75). The test-retest reliability of the KPPS-BG was high and the intraclass correlation coefficient was 0.92, demonstrating \u0430 good repeatability. KPPS-BG total score was higher in patients with postural instability gait difficulty motor subtype, compared to tremor-dominant or indeterminate subtype. Significant positive correlations were found between KPPS-BG total score and modified H&amp;Y, Movement Disorders Society Unified Parkinson\u2019s Disease Rating Scale part III.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The KPPS-BG constitutes a reliable, comprehensive and useful tool for pain assessment in native Bulgarian patients with Parkinson\u2019s disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-021-02392-5","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T03:02:42Z","timestamp":1631674962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Translation, adaptation and validation of the Bulgarian version of the King\u2019s Parkinson\u2019s Disease Pain Scale"],"prefix":"10.1186","volume":"21","author":[{"given":"Galina","family":"Stoyanova-Piroth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Milanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Stambolieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"key":"2392_CR1","doi-asserted-by":"crossref","unstructured":"Parkinson J. An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci. 2002;14:223\u201336.","DOI":"10.1176\/jnp.14.2.223"},{"key":"2392_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/mds.23959","volume":"27","author":"AD Ha","year":"2012","unstructured":"Ha AD, Jankovic J. Pain in Parkinson\u2019s disease. Mov Disord. 2012;27:485\u201391.","journal-title":"Mov Disord"},{"key":"2392_CR3","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/mds.22643","volume":"24","author":"P Barone","year":"2009","unstructured":"Barone P, Antonini A, Colosimo C. et al. The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson\u2019s disease. Mov Disord. 2009;24:1641\u20139.","journal-title":"Mov Disord"},{"key":"2392_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-016-0004-y","volume":"3","author":"P Martinez-Martin","year":"2017","unstructured":"Martinez-Martin P, Manuel Rojo-Abuin J, Rizos A. et al. Distribution and impact on quality of life of the pain modalities assessed by the King\u2019s Parkinson\u2019s disease pain scale. Npj Park Dis. 2017;3:1\u20136.","journal-title":"Npj Park Dis"},{"key":"2392_CR5","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/mds.23135","volume":"25","author":"M Politis","year":"2010","unstructured":"Politis M, Wu K, Molloy S. et al. Parkinson\u2019s disease symptoms: The patient\u2019s perspective. Mov Disord. 2010;25:1646\u201351.","journal-title":"Mov Disord"},{"key":"2392_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/mds.21813","volume":"23","author":"SS O\u2019Sullivan","year":"2008","unstructured":"O\u2019Sullivan SS, Williams DR, Gallagher DA. et al. Nonmotor symptoms as presenting complaints in Parkinson\u2019s disease: A clinicopathological study. Mov Disord. 2008;23:101\u20136.","journal-title":"Mov Disord"},{"key":"2392_CR7","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/mds.24054","volume":"27","author":"MPG Broen","year":"2012","unstructured":"Broen MPG, Braaksma MM, Patijn J. et al. Prevalence of pain in Parkinson\u2019s disease: A systematic review using the modified QUADAS tool. Mov Disord. 2012;27:480\u20134.","journal-title":"Mov Disord"},{"key":"2392_CR8","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1517\/14656560903304063","volume":"10","author":"M Juniper","year":"2009","unstructured":"Juniper M, Le TK, Mladsi D. The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: a literature-based review. Expert Opin Pharmacother. 2009;10:2581\u201392.","journal-title":"Expert Opin Pharmacother"},{"key":"2392_CR9","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/mds.22142","volume":"23","author":"L N\u00e8gre-Pag\u00e8s","year":"2008","unstructured":"N\u00e8gre-Pag\u00e8s L, Regragui W, Bouhassira D. et al. Chronic pain in Parkinson\u2019s disease: The cross-sectional French DoPaMiP survey. Mov Disord. 2008;23:1361\u20139.","journal-title":"Mov Disord"},{"key":"2392_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/mds.22716","volume":"25","author":"B Ford","year":"2010","unstructured":"Ford B. Pain in Parkinson\u2019s disease. Mov Disord. 2010;25:98\u2013103.","journal-title":"Mov Disord"},{"key":"2392_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nrneurol.2012.54","volume":"8","author":"G Wasner","year":"2012","unstructured":"Wasner G, Deuschl G. Pains in Parkinson disease-many syndromes under one umbrella. Nat Rev Neurol. 2012;8:284\u201394.","journal-title":"Nat Rev Neurol"},{"key":"2392_CR12","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/mdc3.12384","volume":"3","author":"S Perez-Lloret","year":"2016","unstructured":"Perez-Lloret S, Ciampi de Andrade D, Lyons KE, Rodr\u00edguez-Bl\u00e1zquez C, Chaudhuri KR, Deuschl G. et al. Rating scales for pain in Parkinson\u2019s disease: Critique and recommendations. Mov Disord Clin Pract. 2016;3:527\u201337.","journal-title":"Mov Disord Clin Pract"},{"key":"2392_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/mdc3.12217","volume":"2","author":"V Mylius","year":"2015","unstructured":"Mylius V, Ciampi de Andrade D, Cury RG, Teepker M, Ehrt U, Eggert KM. et al. Pain in Parkinson\u2019s disease: Current concepts and a new diagnostic algorithm. Mov Disord Clin Pract. 2015;2:357\u201364.","journal-title":"Mov Disord Clin Pract"},{"key":"2392_CR14","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/mds.26270","volume":"30","author":"KR Chaudhuri","year":"2015","unstructured":"Chaudhuri KR, Rizos A, Trenkwalder C. et al. King\u2019s Parkinson\u2019s disease pain scale, the first scale for pain in PD: An international validation: King\u2019s PD Pain Scale Validation. Mov Disord. 2015;30:1623\u201331.","journal-title":"Mov Disord"},{"key":"2392_CR15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/mdc3.12469","volume":"4","author":"M Rodr\u00edguez-Violante","year":"2017","unstructured":"Rodr\u00edguez-Violante M, Alvarado-Bola\u00f1os A, Cervantes-Arriaga A. et al. Clinical Determinants of Parkinson\u2019s Disease-associated Pain Using the King\u2019s Parkinson\u2019s Disease Pain Scale. Mov Disord Clin Pract. 2017;4:545\u201351.","journal-title":"Mov Disord Clin Pract"},{"key":"2392_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.parkreldis.2018.06.001","volume":"56","author":"MA Silverdale","year":"2018","unstructured":"Silverdale MA, Kobylecki C, Kass-Iliyya L. et al. A detailed clinical study of pain in 1957 participants with early\/moderate Parkinson\u2019s disease. Parkinsonism Relat Disord. 2018;56:27\u201332.","journal-title":"Parkinsonism Relat Disord"},{"key":"2392_CR17","doi-asserted-by":"crossref","unstructured":"Mattos DC de, Filho NAM, Pedron CA, et al. Pain Characteristics and Their Relationship With Motor Dysfunction in Individuals With Parkinson Disease\u2014A Cross-Sectional Study. Pain Pract. 2019;19:732\u20139.","DOI":"10.1111\/papr.12803"},{"key":"2392_CR18","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/jcph.678","volume":"56","author":"O Rascol","year":"2016","unstructured":"Rascol O, Zesiewicz T, Chaudhuri KR. et al. A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson\u2019s Disease\u2013Associated Chronic Pain. J Clin Pharmacol. 2016;56:852\u201361.","journal-title":"J Clin Pharmacol"},{"key":"2392_CR19","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/S1474-4422(15)00243-4","volume":"14","author":"C Trenkwalder","year":"2015","unstructured":"Trenkwalder C, Chaudhuri KR, Martinez-Martin P. et al. Prolonged-release oxycodone\u2013naloxone for treatment of severe pain in patients with Parkinson\u2019s disease (PANDA): a double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2015;14:1161\u201370.","journal-title":"Lancet Neurol"},{"issue":"6","key":"2392_CR20","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/ner.12778","volume":"21","author":"M DiMarzio","year":"2018","unstructured":"DiMarzio M, Pilitsis JG, Gee L, et al. King\u2019s Parkinson\u2019s Disease Pain Scale for Assessment of Pain Relief Following Deep Brain Stimulation for Parkinson\u2019s Disease. Neuromodulation. 2018;21(6):617\u201322.","journal-title":"Neuromodulation"},{"key":"2392_CR21","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s00115-017-0333-z","volume":"89","author":"WH Jost","year":"2018","unstructured":"Jost WH, Rizos A, Odin P. et al. King\u2019s Parkinson\u2019s Disease Pain Scale: Interkulturelle Adaption in deutscher Sprache. Nervenarzt. 2018;89:178\u201383.","journal-title":"Nervenarzt"},{"key":"2392_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4103\/NSN.NSN_34_20","volume":"37","author":"F Soyuer","year":"2020","unstructured":"Soyuer F, G\u00fcltekin M, Cankurtaran F. et al. Reliability and validity of the Turkish version of king\u2019s Parkinson\u2019s disease pain scale. Neurol Sci Neurophysiol. 2020;37:57.","journal-title":"Neurol Sci Neurophysiol"},{"issue":"6","key":"2392_CR23","doi-asserted-by":"crossref","first-page":"774","DOI":"10.4103\/aian.AIAN_449_20","volume":"23","author":"M Behari","year":"2020","unstructured":"Behari M, Srivastava A, Achtani R, et al. Pain Assessment in Indian Parkinson\u2019s Disease Patients Using King\u2019s Parkinson\u2019s Disease Pain Scale. Ann Indian Acad Neurol. 2020;23(6):774\u201380.","journal-title":"Ann Indian Acad Neurol"},{"key":"2392_CR24","doi-asserted-by":"publisher","first-page":"135620","DOI":"10.1016\/j.neulet.2020.135620","volume":"6","author":"G Taghizadeh","year":"2021","unstructured":"Taghizadeh G, Joghataei MT, Goudarzi S, et al. King\u2019s Parkinson\u2019s disease pain scale cut-off points for detection of pain severity levels: A reliability and validity study. Neurosci Lett. 2021;6:135620.","journal-title":"Neurosci Lett"},{"key":"2392_CR25","doi-asserted-by":"crossref","unstructured":"Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease. A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181\u20134.","DOI":"10.1136\/jnnp.55.3.181"},{"key":"2392_CR26","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1001\/archpsyc.1983.01790060110016","volume":"40","author":"MF Folstein","year":"1983","unstructured":"Folstein MF, Robins LN, Helzer JE. The Mini-Mental State Examination. Arch Gen Psychiatry. 1983;40:812\u20132.","journal-title":"Arch Gen Psychiatry"},{"key":"2392_CR27","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/mds.20213","volume":"19","author":"CG Goetz","year":"2004","unstructured":"Goetz CG, Poewe W, Rascol O. et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson\u2019s disease. Mov Disord. 2004;19:1020\u20138.","journal-title":"Mov Disord"},{"key":"2392_CR28","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR. et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord Off J Mov Disord Soc. 2008;23:2129\u201370.","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"5","key":"2392_CR29","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mds.25383","volume":"28","author":"GT Stebbins","year":"2013","unstructured":"Stebbins GT, Goetz CG, Burn DJ, et al. How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson\u2019s disease rating scale: comparison with the unified Parkinson\u2019s disease rating scale. Mov Disord. 2013;28(5):668\u201370.","journal-title":"Mov Disord"},{"key":"2392_CR30","doi-asserted-by":"crossref","unstructured":"Tomlinson CL, Stowe R, Patel S. et al. Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease: Systematic Review of LED Reporting in PD. Mov Disord. 2010;25:2649\u201353.","DOI":"10.1002\/mds.23429"},{"key":"2392_CR31","doi-asserted-by":"crossref","unstructured":"Martinez-Martin P, Rizos AM, Wetmore J. et al. First comprehensive tool for screening pain in Parkinson\u2019s disease: The King\u2019s Parkinson\u2019s Disease Pain Questionnaire. Eur J Neurol. 2018;25:1255\u201361.","DOI":"10.1111\/ene.13691"},{"key":"2392_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ijnurstu.2017.11.003","volume":"79","author":"MS Park","year":"2018","unstructured":"Park MS, Kang KJ, Jang SJ, et al. Evaluating test-retest reliability in patient-reported outcome measures for older people: A systematic review. Int J Nurs Stud. 2018;79:58\u201369.","journal-title":"Int J Nurs Stud"},{"key":"2392_CR33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0022-3182(00)70575-9","volume":"32","author":"K Parmenter","year":"2000","unstructured":"Parmenter K, Wardle J. Evaluation and Design of Nutrition Knowledge Measures. J Nutr Educ. 2000;32:269\u201377.","journal-title":"J Nutr Educ"},{"key":"2392_CR34","first-page":"265","volume-title":"Psychometric theory 3th ed","author":"JC Nunnally","year":"1994","unstructured":"Nunnally JC. Psychometric theory 3th ed. New York: Basic Books; 1994. 265 p."},{"issue":"2","key":"2392_CR35","doi-asserted-by":"publisher","first-page":"420\u20138","DOI":"10.1037\/0033-2909.86.2.420","volume":"86","author":"PE Shrout","year":"1979","unstructured":"Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86(2):420\u20138.","journal-title":"Psychol Bull"},{"key":"2392_CR36","unstructured":"Slick DJ. Psychometrics in neuropsychological assessment. In: Strauss E, Sherman E (Eds.). A compendium of neuropsychological tests: Administration, norms, and commentary. New York: Oxford University Press; 2006. (pp. 3\u201343). In."},{"key":"2392_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/1084822302250687","volume":"15","author":"LC Callister","year":"2003","unstructured":"Callister LC. Cultural Influences on Pain Perceptions and Behaviors. Home Health Care Manag Pract. 2003;15:207\u201311.","journal-title":"Home Health Care Manag Pract"},{"key":"2392_CR38","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s00415-017-8426-y","volume":"264","author":"C Buhmann","year":"2017","unstructured":"Buhmann C, Wrobel N, Grashorn W. et al. Pain in Parkinson disease: a cross-sectional survey of its prevalence, specifics, and therapy. J Neurol. 2017;264:758\u201369.","journal-title":"J Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02392-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-021-02392-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02392-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T15:39:36Z","timestamp":1699457976000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-021-02392-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2392"],"URL":"https:\/\/doi.org\/10.1186\/s12883-021-02392-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-256649\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"assertion":[{"value":"2 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of the University Hospital for Active Treatment in Neurology and Psychiatry \u201cSt Naum\u201d, Sofia. All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"357"}}